Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
The evaluation of respiratory muscle functions in patients with severe COPD Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Is there any day variability of respiratory function and airway inflammation in children with mild asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 264s Year: 2006
Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005
Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002
Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)? Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005
Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Respiratory function and airway inflammation in patients with hypothyroidism. The effect of treatment Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients Source: International Congress 2016 – Quality and quantity in lung function Year: 2016
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Problematic severe asthma Source: Eur Respir Mon 2012; 56: 22-39 Year: 2012
Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 541s Year: 2004